Catalyst OrthoScience Inc., a medical device company focused on the upper extremity orthopedics market, has received clearance from the U.S. Food & Drug Administration (FDA) to market its reverse shoulder system. Catalyst’s reverse shoulder system is a single-tray arthroplasty system that is made to combine beneficial and evidence-based attributes of reverse shoulder arthroplasty design. The

The post appeared first on .